Literature DB >> 12032151

Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta.

Puiying A Mak1, Bryan A Laffitte, Catherine Desrumaux, Sean B Joseph, Linda K Curtiss, David J Mangelsdorf, Peter Tontonoz, Peter A Edwards.   

Abstract

Lipid-loaded macrophage "foam cells" accumulate in the subendothelial space during the development of fatty streaks and atherosclerotic lesions. To better understand the consequences of such lipid loading, murine peritoneal macrophages were isolated and incubated with ligands for two nuclear receptors, liver X receptor (LXR) and retinoic acid receptor (RXR). Analysis of the expressed mRNAs using microarray technology led to the identification of four highly induced genes that encode apolipoproteins E, C-I, C-IV, and C-II. Northern blot analysis confirmed that the mRNA levels of these four genes were induced 2-14-fold in response to natural or synthetic ligands for LXR and/or RXR. The induction of all four mRNAs was greatly attenuated in peritoneal macrophages derived from LXRalpha/beta null mice. The two LXR response elements located within the multienhancers ME.1 and ME.2 were shown to be essential for the induction of apoC-II promoter-reporter genes by ligands for LXR and/or RXR. Finally, immunohistochemical studies demonstrate that apoC-II protein co-localizes with macrophages within murine arterial lesions. Taken together, these studies demonstrate that activated LXR induces the expression of the apoE/C-I/C-IV/C-II gene cluster in both human and murine macrophages. These results suggest an alternative mechanism by which lipids are removed from macrophage foam cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032151     DOI: 10.1074/jbc.M202993200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  Tgif1 represses apolipoprotein gene expression in liver.

Authors:  Tiffany A Melhuish; David D Chung; Glen A Bjerke; David Wotton
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

2.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Authors:  Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 3.  Liver X receptors as integrators of metabolic and inflammatory signaling.

Authors:  Noam Zelcer; Peter Tontonoz
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

Review 4.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

5.  The HDL proteome: a marker--and perhaps mediator--of coronary artery disease.

Authors:  Jay W Heinecke
Journal:  J Lipid Res       Date:  2008-12-05       Impact factor: 5.922

6.  Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages.

Authors:  Ana Ramón-Vázquez; Juan Vladimir de la Rosa; Carlos Tabraue; Felix Lopez; Bonifacio Nicolas Díaz-Chico; Lisardo Bosca; Peter Tontonoz; Susana Alemany; Antonio Castrillo
Journal:  Mol Cell Biol       Date:  2019-02-15       Impact factor: 4.272

Review 7.  Minireview: liver X receptor beta: emerging roles in physiology and diseases.

Authors:  Chiara Gabbi; Margaret Warner; Jan-Ake Gustafsson
Journal:  Mol Endocrinol       Date:  2008-12-12

Review 8.  Liver X receptors in lipid signalling and membrane homeostasis.

Authors:  Bo Wang; Peter Tontonoz
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

9.  24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury.

Authors:  Casandra M Cartagena; Mark P Burns; G William Rebeck
Journal:  Brain Res       Date:  2010-01-04       Impact factor: 3.252

Review 10.  MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders.

Authors:  Neetu Sud; Jennifer Taher; Qiaozhu Su
Journal:  Drug Dev Res       Date:  2015-08-19       Impact factor: 4.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.